Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.40, $0.06 better than the analyst estimate of $0.34. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.28 billion.

GUIDANCE:

Elanco Animal Health sees FY2026 EPS of $1.03-$1.09, versus the consensus of $1.03. Elanco Animal Health sees FY2026 revenue of $5.01-5.085 billion, versus the consensus of $5 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.